speb/financial-data huggingface dataset:
Financial ratios for CPFE3.SA — quarterly report dated 2025-03-31
Total revenue: 1849796006.9444444
Gross profit: 679598263.888889
Operating income: 564141319.4444444
Net income: 280450000
Capital expenditures: 10348437.5
Operating cash flow: 363480555.5555556
Depreciation & amortization: 102434027.77777778
Net tangible assets: 2553620138.888889
Owner earnings: 372535590.2777778
Return on net tangible assets (%): 14.588528050999495
Capex to operating income (%): 1.8343697125732508
Buffett classification: The Great
Stock price: 6.062500000000001
P/E ratio: 6.227083742645749
Shares outstanding: 1152254440
Book value: 4057269444.4444447
P/B ratio: 1.7217349348254882
Market cap (USD): 6985542542.500001
Debt to equity: 1.3207255050434166
Current ratio: 0.9858220596873503
Quick ratio: 0.9732830046548943
Effective tax rate (%): 32.47611125508916
Interest coverage ratio: 4.561469461094656
COGS to revenue (%): 63.26090761697165
SG&A to revenue (%): 2.6310239727072005
Free cash flow (dilution-adjusted): 352458680.5555556
Buyback yield (%): 0
Retained earnings: 271817187.5
Inventory turnover: 30.602294602644196
Receivables turnover: 1.6971430027739305
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.314416762020597
FCF margin (%): 19.05392158012919
Rule of 40 score: 19.05392158012919
Financial ratios for CPFE3.SA — quarterly report dated 2025-06-30
Total revenue: 1925022810.218978
Gross profit: 579681204.379562
Operating income: 460274270.0729927
Net income: 216387408.75912407
Capital expenditures: 11533029.197080292
Operating cash flow: 345619525.54744524
Depreciation & amortization: 109971897.81021897
Net tangible assets: 2590850547.4452553
Owner earnings: 314826277.3722627
Return on net tangible assets (%): 12.151464224082767
Capex to operating income (%): 2.505686271633503
Buffett classification: The Great
Stock price: 6.906934306569343
P/E ratio: 16.018410814535297
Shares outstanding: 1152254440
Book value: 4094463321.167883
P/B ratio: 1.9437335487628187
Market cap (USD): 7958545721.532846
Debt to equity: 1.4067523265239033
Current ratio: 0.8766180450996045
Quick ratio: 0.8641197806899592
Effective tax rate (%): 32.57556373577511
Interest coverage ratio: 4.043876075378286
COGS to revenue (%): 69.8870475039399
SG&A to revenue (%): 2.820376097543635
Free cash flow (dilution-adjusted): 333322810.21897805
Buyback yield (%): 0
Retained earnings: 493109671.5328467
Inventory turnover: 32.10629412046493
Receivables turnover: 1.8877916320766517
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.144058221459667
FCF margin (%): 17.31526548410413
Revenue growth (%): 4.066762118207601
Rule of 40 score: 21.38202760231173
Financial ratios for CPFE3.SA — quarterly report dated 2025-09-30
Total revenue: 2129538345.8646615
Gross profit: 620300000
Operating income: 503278383.4586466
Net income: 258719172.93233082
Capital expenditures: 22561842.105263155
Operating cash flow: 361026315.78947365
Depreciation & amortization: 112755639.09774436
Net tangible assets: 2909732894.736842
Owner earnings: 348912969.924812
Return on net tangible assets (%): 11.991237084198682
Capex to operating income (%): 4.482974601494486
Buffett classification: The Great
Stock price: 6.859022556390977
P/E ratio: 10.46028766895068
Shares outstanding: 1152254440
Book value: 4452697180.451126
P/B ratio: 1.7749554650516173
Market cap (USD): 7903339194.6616535
Debt to equity: 1.4508104384986902
Current ratio: 1.0055208910693973
Quick ratio: 0.9927530602047989
Effective tax rate (%): 24.65074520645435
Interest coverage ratio: 4.575242394933715
COGS to revenue (%): 70.87162101567426
SG&A to revenue (%): 3.165049362952753
Free cash flow (dilution-adjusted): 337223496.2406015
Buyback yield (%): 0
Retained earnings: 756858270.6766917
Inventory turnover: 34.141888846366456
Receivables turnover: 1.9116027021609325
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.18159364506204
FCF margin (%): 15.835521200895672
Revenue growth (%): 10.624057780511139
Rule of 40 score: 26.45957898140681
Financial ratios for CPFE3.SA — quarterly report dated 2025-12-31
Total revenue: 2159542700.729927
Gross profit: 681143978.1021898
Operating income: 478187226.27737224
Net income: 285578649.63503647
Capital expenditures: 23194160.583941605
Operating cash flow: 228922262.77372262
Depreciation & amortization: 110345072.99270073
Net tangible assets: 2846156204.379562
Owner earnings: 372729562.0437956
Return on net tangible assets (%): 13.095892680459803
Capex to operating income (%): 4.850434998965833
Buffett classification: The Great
Stock price: 8.861759425493716
P/E ratio: 9.807565181736607
Shares outstanding: 1152254440
Book value: 4289144160.5839405
P/B ratio: 2.380661796838934
Market cap (USD): 10211001644.236984
Debt to equity: 1.4239129852100727
Current ratio: 0.9295339221724725
Quick ratio: 0.916300173590648
Effective tax rate (%): 25.954144657528023
Interest coverage ratio: 3.6201382039018704
COGS to revenue (%): 68.45887891580182
SG&A to revenue (%): 4.209393479661735
Free cash flow (dilution-adjusted): 204655656.93430656
Buyback yield (%): 0
Retained earnings: 0
Inventory turnover: 34.24678525231859
Receivables turnover: 1.8951669159543019
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.14473517613977
FCF margin (%): 9.476805291469013
Revenue growth (%): 1.4089605347342486
Rule of 40 score: 10.885765826203261
Financial ratios for CPFE3.SA — annual report dated 2025-12-31
Total revenue: 8096310401.459853
Gross profit: 2577408211.678832
Operating income: 2051630839.4160583
Net income: 1047910948.9051094
Capital expenditures: 67507481.75182481
Operating cash flow: 1307079744.5255473
Depreciation & amortization: 437448357.66423357
Net tangible assets: 2846156204.379562
Owner earnings: 1417851824.8175182
Return on net tangible assets (%): 49.81637419041792
Capex to operating income (%): 3.290430249675863
Buffett classification: The Great
Stock price: 8.861759425493716
P/E ratio: 9.744150163623885
Shares outstanding: 1152254440
Book value: 4289144160.5839405
P/B ratio: 2.380661796838934
Market cap (USD): 10211001644.236984
Debt to equity: 1.4239129852100727
Current ratio: 0.9295339221724725
Quick ratio: 0.916300173590648
Effective tax rate (%): 29.027593525150515
Interest coverage ratio: 4.250374267909287
COGS to revenue (%): 68.16564479526258
SG&A to revenue (%): 3.2333958734605184
Free cash flow (dilution-adjusted): 1235823540.1459854
Buyback yield (%): 0
Retained earnings: 0
Inventory turnover: 127.84417033724202
Receivables turnover: 7.1051429587186075
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.7827136345304
FCF margin (%): 15.264033601319843
Revenue growth (%): 17.375784564977504
Rule of 40 score: 32.639818166297346
Financial ratios for CPRI — annual report dated 2022-03-31
Total revenue: 7439473684.210526
Gross profit: 4926315789.473684
Operating income: 1339473684.2105262
Net income: 1082894736.8421052
Capital expenditures: 172368421.0526316
Operating cash flow: 926315789.4736842
Depreciation & amortization: 253947368.42105263
Net tangible assets: -928947368.4210526
Owner earnings: 1164473684.2105262
Return on net tangible assets (%): -125.3541076487252
Capex to operating income (%): 12.868369351669942
Buffett classification: The Great
Stock price: 51.39
P/E ratio: 5.447779628649333
Shares outstanding: 114796106
Book value: 3365789473.68421
P/B ratio: 1.7527453613676314
Market cap (USD): 5899371887.34
Debt to equity: 1.1888193901485538
Current ratio: 1.2075351213282248
Quick ratio: 0.5076628352490422
Effective tax rate (%): 10.054644808743168
COGS to revenue (%): 33.78139370357269
SG&A to revenue (%): 44.800141492748494
Free cash flow (dilution-adjusted): 642105263.1578947
Buyback yield (%): 14.742871931361211
Retained earnings: 6700000000
Inventory turnover: 1.7427007299270074
Receivables turnover: 12.185344827586208
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.213391951301997
FCF margin (%): 8.631057658295012
Rule of 40 score: 8.631057658295012
Financial ratios for CPRI — annual report dated 2023-03-31
Total revenue: 6937037037.037037
Gross profit: 4597530864.197531
Operating income: 1033333333.3333333
Net income: 764197530.8641975
Capital expenditures: 279012345.6790123
Operating cash flow: 951851851.8518518
Depreciation & amortization: 220987654.32098764
Net tangible assets: -1448148148.148148
Owner earnings: 706172839.5061729
Return on net tangible assets (%): -48.76385336743393
Capex to operating income (%): 27.001194743130224
Buffett classification: The Good
Stock price: 47
P/E ratio: 7.060238700193862
Shares outstanding: 114796106
Book value: 2282716049.382716
P/B ratio: 2.3635953247268793
Market cap (USD): 5395416982
Debt to equity: 1.9491617090319089
Current ratio: 1.2896551724137932
Quick ratio: 0.5606896551724139
Effective tax rate (%): 4.475308641975309
COGS to revenue (%): 33.72486207510233
SG&A to revenue (%): 48.193628759565755
Free cash flow (dilution-adjusted): 576543209.8765432
Buyback yield (%): 31.21075948164687
Retained earnings: 7046913580.246913
Inventory turnover: 1.792809839167455
Receivables turnover: 13.638349514563107
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.319931565440546
FCF margin (%): 8.311087382096458
Revenue growth (%): -6.753658504631272
Rule of 40 score: 1.5574288774651865
Financial ratios for CPRI — annual report dated 2024-03-31
Total revenue: 5240506329.113924
Gross profit: 3310126582.278481
Operating income: 444303797.4683544
Net income: -289873417.721519
Capital expenditures: 170886075.94936708
Operating cash flow: 391139240.5063291
Depreciation & amortization: 167088607.5949367
Net tangible assets: -1140506329.113924
Owner earnings: -293670886.0759494
Capex to operating income (%): 38.46153846153847
Buffett classification: The Good
Stock price: 45.3
Shares outstanding: 114796106
Book value: 2025316455.6962023
P/B ratio: 2.56763015338875
Market cap (USD): 5200263601.799999
Debt to equity: 2.234375
Current ratio: 0.9486725663716814
Quick ratio: 0.440117994100295
Effective tax rate (%): 38.095238095238095
COGS to revenue (%): 36.83574879227053
SG&A to revenue (%): 51.4975845410628
Free cash flow (dilution-adjusted): 150632911.39240503
Buyback yield (%): 2.604541776070771
Retained earnings: 6935443037.974683
Inventory turnover: 1.7691415313225058
Receivables turnover: 10.837696335078535
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.028434120945133
FCF margin (%): 2.8743961352657
Revenue growth (%): -24.456128731406327
Rule of 40 score: -21.581732596140625
Financial ratios for CPRI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 42.44
Shares outstanding: 114796106
Market cap (USD): 4871946738.639999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPRI — quarterly report dated 2024-12-31
Total revenue: 1335000000
Gross profit: 842500000
Operating income: 131250000
Net income: -682500000
Capital expenditures: 27500000
Operating cash flow: 386250000
Depreciation & amortization: 40000000
Net tangible assets: -872500000
Owner earnings: -670000000
Capex to operating income (%): 20.952380952380953
Buffett classification: The Great
Stock price: 21.06
Shares outstanding: 114796106
Book value: 1338750000
P/B ratio: 1.8058681548907562
Market cap (USD): 2417605992.3599997
Debt to equity: 2.910364145658263
Current ratio: 1.2132867132867133
Quick ratio: 0.5895104895104896
Effective tax rate (%): 68.42105263157895
COGS to revenue (%): 36.89138576779026
SG&A to revenue (%): 50.28089887640449
Free cash flow (dilution-adjusted): 347500000
Buyback yield (%): 0
Retained earnings: 6177500000
Inventory turnover: 0.44170403587443946
Receivables turnover: 3.608108108108108
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.346368715083799
FCF margin (%): 26.02996254681648
Rule of 40 score: 26.02996254681648
Financial ratios for CPRI — quarterly report dated 2025-03-31
Total revenue: 1344155844.1558442
Gross profit: 819480519.4805194
Operating income: -38961038.96103896
Net income: -836363636.3636364
Capital expenditures: 35064935.064935066
Operating cash flow: -209090909.0909091
Depreciation & amortization: 62337662.33766234
Net tangible assets: -536363636.3636364
Owner earnings: -809090909.0909091
Buffett classification: The Gruesome
Stock price: 19.73
Shares outstanding: 114796106
Book value: 483116883.1168833
P/B ratio: 4.688155704200536
Market cap (USD): 2264927171.38
Debt to equity: 6.862903225806449
Current ratio: 1.1384730538922156
Quick ratio: 0.6137724550898204
COGS to revenue (%): 39.03381642512077
SG&A to revenue (%): 59.22705314009662
Free cash flow (dilution-adjusted): -257142857.14285713
Buyback yield (%): 0
Retained earnings: 5580519480.519481
Inventory turnover: 0.5763195435092725
Receivables turnover: 3.9961389961389964
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7737941707505803
FCF margin (%): -19.130434782608692
Revenue growth (%): 0.6858310229096788
Rule of 40 score: -18.444603759699014
Financial ratios for CPRI — annual report dated 2025-03-31
Total revenue: 4702597402.597403
Gross profit: 2923376623.376623
Operating income: 157142857.14285713
Net income: -1531168831.168831
Capital expenditures: 96103896.1038961
Operating cash flow: 364935064.9350649
Depreciation & amortization: 171428571.42857143
Net tangible assets: -536363636.3636364
Owner earnings: -1455844155.8441558
Capex to operating income (%): 61.15702479338842
Buffett classification: The Good
Stock price: 19.73
Shares outstanding: 114796106
Book value: 483116883.1168833
P/B ratio: 4.688155704200536
Market cap (USD): 2264927171.38
Debt to equity: 6.862903225806449
Current ratio: 1.1384730538922156
Quick ratio: 0.6137724550898204
COGS to revenue (%): 37.83485225075946
SG&A to revenue (%): 55.1781275890638
Free cash flow (dilution-adjusted): 203896103.8961039
Buyback yield (%): 0.22935859750581059
Retained earnings: 5580519480.519481
Inventory turnover: 1.9543509272467903
Receivables turnover: 13.980694980694981
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.12096982202734
FCF margin (%): 4.3358188345760835
Revenue growth (%): -10.264445699228308
Rule of 40 score: -5.928626864652224
Financial ratios for CPRI — quarterly report dated 2025-06-30
Total revenue: 1091780821.9178083
Gross profit: 687671232.8767123
Operating income: 23287671.232876714
Net income: 72602739.7260274
Capital expenditures: 17808219.17808219
Operating cash flow: -10958904.109589042
Depreciation & amortization: 41095890.41095891
Net tangible assets: -1117808219.1780822
Owner earnings: 95890410.95890412
Return on net tangible assets (%): -8.57843137254902
Capex to operating income (%): 76.4705882352941
Buffett classification: The Gruesome
Stock price: 17.7
P/E ratio: 6.996606064273585
Shares outstanding: 114796106
Book value: -17808219.178082466
Market cap (USD): 2031891076.1999998
Debt to equity: -209.23076923076601
Current ratio: 1.1715511079342389
Quick ratio: 0.6147248034310222
Effective tax rate (%): -40
COGS to revenue (%): 37.0138017565872
SG&A to revenue (%): 57.08908406524466
Free cash flow (dilution-adjusted): -47945205.47945206
Buyback yield (%): 0.06741813228790391
Retained earnings: 5958904109.589042
Inventory turnover: 0.37869062901155326
Receivables turnover: 3.9261083743842367
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.41769041769041776
FCF margin (%): -4.391468005018821
Revenue growth (%): -18.775726292105084
Rule of 40 score: -23.167194297123906
Financial ratios for CPRI — quarterly report dated 2025-09-30
Total revenue: 1156756756.7567568
Gross profit: 705405405.4054054
Operating income: 14864864.864864865
Net income: -37837837.83783784
Capital expenditures: 17567567.56756757
Operating cash flow: -70270270.27027027
Depreciation & amortization: 40540540.54054054
Net tangible assets: -1158108108.108108
Owner earnings: -14864864.864864867
Capex to operating income (%): 118.18181818181819
Buffett classification: The Gruesome
Stock price: 19.92
Shares outstanding: 114796106
Book value: -94594594.59459496
Market cap (USD): 2286738431.52
Debt to equity: -41.099999999999845
Current ratio: 1.2518355359765052
Quick ratio: 0.6894273127753305
Effective tax rate (%): 1800
COGS to revenue (%): 39.018691588785046
SG&A to revenue (%): 56.19158878504673
Free cash flow (dilution-adjusted): -97297297.2972973
Buyback yield (%): 0.0590951432277764
Retained earnings: 5840540540.540541
Inventory turnover: 0.4360313315926893
Receivables turnover: 3.522633744855967
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.2585193889541716
FCF margin (%): -8.411214953271028
Revenue growth (%): 5.951371697921254
Rule of 40 score: -2.4598432553497735
Financial ratios for CPRI — quarterly report dated 2025-12-31
Total revenue: 1385135135.1351352
Gross profit: 841891891.891892
Operating income: 78378378.37837838
Net income: 156756756.75675675
Capital expenditures: 25675675.675675675
Operating cash flow: 272972972.972973
Depreciation & amortization: 40540540.54054054
Net tangible assets: -909459459.4594594
Owner earnings: 171621621.6216216
Return on net tangible assets (%): -18.87072808320951
Capex to operating income (%): 32.758620689655174
Buffett classification: The Good
Stock price: 24.4
P/E ratio: 4.467151917965517
Shares outstanding: 114796106
Book value: 145945945.94594574
P/B ratio: 19.192208240148172
Market cap (USD): 2801024986.3999996
Debt to equity: 12.138888888888905
Current ratio: 1.138188608776844
Quick ratio: 0.519140989729225
Effective tax rate (%): -3.6363636363636367
COGS to revenue (%): 39.21951219512195
SG&A to revenue (%): 52.19512195121951
Free cash flow (dilution-adjusted): 237837837.83783785
Buyback yield (%): 0
Retained earnings: 5997297297.2972975
Inventory turnover: 0.6063348416289592
Receivables turnover: 4.834905660377358
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.564102564102564
FCF margin (%): 17.170731707317074
Revenue growth (%): 19.74299065420561
Rule of 40 score: 36.91372236152269
Financial ratios for CRGY — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.4
Shares outstanding: 330251628
Market cap (USD): 3434616931.2000003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRGY — annual report dated 2022-12-31
Total revenue: 3057065000
Gross profit: 2618312000
Operating income: 1486274000
Net income: 480600000
Capital expenditures: 1126124000
Operating cash flow: 1012372000
Depreciation & amortization: 532926000
Net tangible assets: 848113000
Owner earnings: -112598000
Return on net tangible assets (%): -13.276296908548742
Capex to operating income (%): 75.76826345613257
Buffett classification: The Gruesome
Stock price: 10.24
P/E ratio: 7.036572348564294
Shares outstanding: 330251628
Book value: 3298994000
P/B ratio: 1.0250933074506956
Market cap (USD): 3381776670.7200003
Debt to equity: 0.3991174279189353
Current ratio: 0.5781701573931831
Quick ratio: 0.5781701573931831
Effective tax rate (%): 7.0210160362629646
Interest coverage ratio: 15.49218758143365
COGS to revenue (%): 14.35209915392705
SG&A to revenue (%): 8.671192794395932
Free cash flow (dilution-adjusted): -245018000
Buyback yield (%): 0
Retained earnings: 61957000
Receivables turnover: 6.649378360507404
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 28.994245137628997
FCF margin (%): -8.01481159216438
Rule of 40 score: -8.01481159216438
Financial ratios for CRGY — annual report dated 2023-12-31
Total revenue: 2382602000
Gross profit: 1800629000
Operating income: 478235000
Net income: 321991000
Capital expenditures: 1401658000
Operating cash flow: 935769000
Depreciation & amortization: 675782000
Net tangible assets: 1704823000
Owner earnings: -403885000
Return on net tangible assets (%): -23.6907291842027
Capex to operating income (%): 293.08979894821584
Buffett classification: The Gruesome
Stock price: 11.83
P/E ratio: 12.13349677239426
Shares outstanding: 330251628
Book value: 3635718000
P/B ratio: 1.0745819008074884
Market cap (USD): 3906876759.2400002
Debt to equity: 0.4853294452430029
Current ratio: 0.8205881451289359
Quick ratio: 0.8205881451289359
Effective tax rate (%): 6.7282123180135445
Interest coverage ratio: 3.2799179737598334
COGS to revenue (%): 24.425942729839058
SG&A to revenue (%): 15.784046181443648
Free cash flow (dilution-adjusted): -577771000
Buyback yield (%): 0.0018429043053307386
Retained earnings: 95447000
Receivables turnover: 4.701841977511061
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.900691185542298
FCF margin (%): -24.24958092035514
Revenue growth (%): -22.062435702217652
Rule of 40 score: -46.31201662257279
Financial ratios for CRGY — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.12
Shares outstanding: 330251628
Market cap (USD): 3342146475.3599997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRGY — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.62
Shares outstanding: 330251628
Market cap (USD): 4498027173.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRGY — annual report dated 2024-12-31
Total revenue: 2930919000
Gross profit: 2298877000
Operating income: 420455000
Net income: -114605000
Capital expenditures: 1189513000
Operating cash flow: 1223086000
Depreciation & amortization: 949480000
Net tangible assets: 3130295000
Owner earnings: -354638000
Return on net tangible assets (%): -11.329219770021675
Capex to operating income (%): 282.9108941503847
Buffett classification: The Gruesome
Stock price: 13.62
Shares outstanding: 330251628
Book value: 4367960000
P/B ratio: 1.0297775559666298
Market cap (USD): 4498027173.36
Debt to equity: 0.7173591333253968
Current ratio: 0.952529905253196
Quick ratio: 0.952529905253196
Interest coverage ratio: 1.9441837022514254
COGS to revenue (%): 21.564635528992785
SG&A to revenue (%): 19.764073998633194
Free cash flow (dilution-adjusted): -206811000
Buyback yield (%): 0.341949912866144
Retained earnings: -64751000
Receivables turnover: 5.404887215272041
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.04548865837558
FCF margin (%): -7.056182719481501
Revenue growth (%): 23.013369417133035
Rule of 40 score: 15.957186697651533
Financial ratios for CRGY — quarterly report dated 2025-03-31
Total revenue: 950172000
Gross profit: 758167000
Operating income: 209332000
Net income: 5911000
Capital expenditures: 1056942000
Operating cash flow: 337114000
Depreciation & amortization: 282573000
Net tangible assets: 3255445000
Owner earnings: -768458000
Return on net tangible assets (%): -23.605313559282987
Capex to operating income (%): 504.9118147249345
Buffett classification: The Gruesome
Stock price: 10.6
P/E ratio: 148.0573192691592
Shares outstanding: 330251628
Book value: 4433898000
P/B ratio: 0.7895236328846537
Market cap (USD): 3500667256.7999997
Debt to equity: 0.8304985816092296
Current ratio: 0.7806114416328707
Quick ratio: 0.7806114416328707
Effective tax rate (%): 30.654622243078368
Interest coverage ratio: 2.8604301604219615
COGS to revenue (%): 20.207394029712518
SG&A to revenue (%): 18.497598329565594
Free cash flow (dilution-adjusted): -752984000
Buyback yield (%): 0.15174249965293074
Retained earnings: -66901000
Receivables turnover: 1.550594912684671
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3253527680742434
FCF margin (%): -79.24712578354234
Rule of 40 score: -79.24712578354234
Financial ratios for CRGY — quarterly report dated 2025-06-30
Total revenue: 897983000
Gross profit: 737833000
Operating income: 82479000
Net income: 162498000
Capital expenditures: 212104000
Operating cash flow: 498966000
Depreciation & amortization: 297056000
Net tangible assets: 4487774000
Owner earnings: 247450000
Return on net tangible assets (%): 5.513869459558347
Capex to operating income (%): 257.16121679457797
Buffett classification: The Gruesome
Stock price: 8.22
P/E ratio: 16.119497070584117
Shares outstanding: 330251628
Book value: 4498724000
P/B ratio: 0.6034307466205974
Market cap (USD): 2714668382.1600003
Debt to equity: 0.7727520070135443
Current ratio: 0.884541360623301
Quick ratio: 0.884541360623301
Effective tax rate (%): 20.16997862985434
Interest coverage ratio: 1.0965181669524986
COGS to revenue (%): 17.83441334635511
SG&A to revenue (%): 27.64829623723389
Free cash flow (dilution-adjusted): 109153000
Buyback yield (%): 1.0504413794111553
Retained earnings: 55766000
Receivables turnover: 1.5059779063156677
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9159152306178805
FCF margin (%): 12.155352606897903
Revenue growth (%): -5.4925845004904374
Rule of 40 score: 6.662768106407466
Financial ratios for CRGY — quarterly report dated 2025-09-30
Total revenue: 866579000
Gross profit: 702874000
Operating income: 125612000
Net income: -9507000
Capital expenditures: 249993000
Operating cash flow: 473060000
Depreciation & amortization: 298450000
Net tangible assets: 4470584000
Owner earnings: 38950000
Capex to operating income (%): 199.01999808935452
Buffett classification: The Gruesome
Stock price: 8.64
P/E ratio: 17.956816565681994
Shares outstanding: 330251628
Book value: 4478881000
P/B ratio: 0.6370729800412201
Market cap (USD): 2853374065.92
Debt to equity: 0.7463136439659817
Current ratio: 0.8131354157264886
Quick ratio: 0.8131354157264886
Interest coverage ratio: 1.7295019895633976
COGS to revenue (%): 18.890949353723087
SG&A to revenue (%): 19.75169026713087
Free cash flow (dilution-adjusted): 175852000
Buyback yield (%): 0.0020326812629559428
Retained earnings: 15705000
Receivables turnover: 1.6517467082440664
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.422558811977888
FCF margin (%): 20.29266806603899
Revenue growth (%): -3.4971708818541107
Rule of 40 score: 16.795497184184878
Financial ratios for CRGY — quarterly report dated 2025-12-31
Total revenue: 865047000
Gross profit: 582683000
Operating income: 19194000
Net income: 9023000
Capital expenditures: 596274000
Operating cash flow: 371016000
Depreciation & amortization: 288823000
Net tangible assets: 5157907000
Owner earnings: -298428000
Return on net tangible assets (%): -5.785835223473397
Capex to operating income (%): 3106.5645514223197
Buffett classification: The Gruesome
Stock price: 8.23
P/E ratio: 16.185623929968738
Shares outstanding: 330251628
Book value: 5165435000
P/B ratio: 0.5261843191212356
Market cap (USD): 2717970898.44
Debt to equity: 1.105340402115214
Current ratio: 1.477709580600594
Quick ratio: 1.477709580600594
Effective tax rate (%): -132.01337104654152
Interest coverage ratio: 0.2479748846943917
COGS to revenue (%): 32.64146341181462
SG&A to revenue (%): 21.450279580184663
Free cash flow (dilution-adjusted): 132759000
Buyback yield (%): 0.17428442676552708
Retained earnings: 0
Receivables turnover: 1.164522625512564
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.17162344025328807
FCF margin (%): 15.347027386951229
Revenue growth (%): -0.17678711346570827
Rule of 40 score: 15.17024027348552
Financial ratios for CRGY — annual report dated 2025-12-31
Total revenue: 3579782000
Gross profit: 2811968000
Operating income: 436618000
Net income: 167166000
Capital expenditures: 922765000
Operating cash flow: 1680156000
Depreciation & amortization: 1166902000
Net tangible assets: 5157907000
Owner earnings: 411303000
Return on net tangible assets (%): 7.974222877612955
Capex to operating income (%): 211.34378335295386
Buffett classification: The Gruesome
Stock price: 8.23
P/E ratio: 16.259113087828865
Shares outstanding: 330251628
Book value: 5165435000
P/B ratio: 0.5261843191212356
Market cap (USD): 2717970898.44
Debt to equity: 1.105340402115214
Current ratio: 1.477709580600594
Quick ratio: 1.477709580600594
Effective tax rate (%): 17.10913869192245
Interest coverage ratio: 1.4630401565515763
COGS to revenue (%): 21.448624525180584
SG&A to revenue (%): 21.810126985386262
Free cash flow (dilution-adjusted): -335220000
Buyback yield (%): 1.421023309048966
Retained earnings: 0
Receivables turnover: 4.819087440801041
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.90402642682662
FCF margin (%): -9.364257376566506
Revenue growth (%): 22.13855108244206
Rule of 40 score: 12.774293705875554
Financial ratios for CTE.NS — annual report dated 2022-03-31
Total revenue: 14801921.139390742
Gross profit: 3501804.9584597126
Operating income: 1376841.8831596994
Net income: 1291786.8917315048
Capital expenditures: 3398639.7204272714
Operating cash flow: 844993.2744296453
Depreciation & amortization: 865594.3557958591
Net tangible assets: 8759382.038770935
Owner earnings: -1241258.4728999077
Return on net tangible assets (%): -14.170616915734776
Capex to operating income (%): 246.84313877986992
Buffett classification: The Gruesome
Stock price: 0.8222339443492022
P/E ratio: 12.253288427378767
Shares outstanding: 19250771
Book value: 11260232.889357774
P/B ratio: 1.4057113673068995
Market cap (USD): 15828637.371093234
Debt to equity: 0.4178425084497702
Current ratio: 2.6173665399114308
Quick ratio: 2.6173665399114308
Effective tax rate (%): 16.67448547093204
Interest coverage ratio: 17.675008210625396
COGS to revenue (%): 76.34222662394315
SG&A to revenue (%): 1.7023293610696395
Free cash flow (dilution-adjusted): -2555413.5566398525
Buyback yield (%): 0
Retained earnings: 10693027.297903204
Receivables turnover: 3.9665157741341033
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.898713178626041
FCF margin (%): -17.264066823322064
Rule of 40 score: -17.264066823322064
Financial ratios for CTE.NS — annual report dated 2023-03-31
Total revenue: 22167121.80267966
Gross profit: 4670321.5590743
Operating income: 1449576.3702801464
Net income: 994716.808769793
Capital expenditures: 1038973.6906211937
Operating cash flow: -2686162.3629719857
Depreciation & amortization: 1063574.665042631
Net tangible assets: 10259779.17174178
Owner earnings: 1019317.7831912304
Return on net tangible assets (%): 9.935085016241954
Capex to operating income (%): 71.6742982241357
Buffett classification: The Good
Stock price: 0.6059683313032888
P/E ratio: 11.727315228138918
Shares outstanding: 19250771
Book value: 12084771.619975641
P/B ratio: 0.9652940035614224
Market cap (USD): 11665357.579171743
Debt to equity: 0.5737762190010227
Current ratio: 2.4403776988696553
Quick ratio: 2.4403776988696553
Effective tax rate (%): 19.684353966823114
Interest coverage ratio: 6.833223379559853
COGS to revenue (%): 78.9313127764303
SG&A to revenue (%): 2.1927318041934463
Free cash flow (dilution-adjusted): -3726174.421437272
Buyback yield (%): 0
Retained earnings: 10818734.835566383
Receivables turnover: 3.2979817175847095
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.939710324925683
FCF margin (%): -16.809464280504088
Revenue growth (%): 49.75841037072352
Rule of 40 score: 32.94894609021943
Financial ratios for CTE.NS — annual report dated 2024-03-31
Total revenue: 24730486.149418395
Gross profit: 5188596.834152776
Operating income: 1460397.050005996
Net income: 668972.298836791
Capital expenditures: 4531166.806571531
Operating cash flow: 1489245.4730783068
Depreciation & amortization: 1173508.2144141984
Net tangible assets: 7178510.852620218
Owner earnings: -2688686.2933205417
Return on net tangible assets (%): -37.454652483239585
Capex to operating income (%): 310.26951242834457
Buffett classification: The Gruesome
Stock price: 1.0010796545105567
P/E ratio: 28.807702823048462
Shares outstanding: 19250771
Book value: 13486808.250389732
P/B ratio: 1.4289188979301273
Market cap (USD): 19271555.181741845
Debt to equity: 1.075461897122889
Current ratio: 1.829334292299981
Quick ratio: 1.7993419069540058
Effective tax rate (%): 30.619593880561023
Interest coverage ratio: 1.3804410564497847
COGS to revenue (%): 81.21447455287297
SG&A to revenue (%): 1.502132179019906
Free cash flow (dilution-adjusted): -3042161.170404125
Buyback yield (%): 0
Retained earnings: 11265406.763400888
Inventory turnover: 64.18594027662328
Receivables turnover: 4.2519363676052695
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.565564520084188
FCF margin (%): -12.30125906957017
Revenue growth (%): 11.563812251118962
Rule of 40 score: -0.7374468184512075
Financial ratios for CTE.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 9045723.841376016
Buffett classification: The Gruesome
Stock price: 1.298853320592451
Shares outstanding: 19250771
Book value: 9045723.841376014
P/B ratio: 2.7641710354835816
Market cap (USD): 25003927.83731486
Debt to equity: 1.683519783232186
Current ratio: 1.5760417906157258
Quick ratio: 1.5760417906157258
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTE.NS — quarterly report dated 2024-12-31
Total revenue: 6012822.007226949
Gross profit: 858934.6077631424
Operating income: -292901.2705443525
Net income: -516691.922135447
Capital expenditures: 0
Depreciation & amortization: 388809.88460193493
Owner earnings: -127882.03753351205
Buffett classification: The Gruesome
Stock price: 1.2249679449819326
Shares outstanding: 19250771
Market cap (USD): 23581577.391187783
Interest coverage ratio: -0.7837559651913539
COGS to revenue (%): 85.71495037220845
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTE.NS — quarterly report dated 2025-03-31
Total revenue: 5907072.714519522
Gross profit: 1825309.7965863922
Operating income: -686778.1155015198
Net income: -728559.7381342062
Capital expenditures: 0
Depreciation & amortization: 757797.5216273088
Net tangible assets: 7943242.92728548
Owner earnings: 29237.783493102645
Buffett classification: The Gruesome
Stock price: 0.3987629828451395
Shares outstanding: 19250771
Book value: 7943242.927285479
P/B ratio: 0.966418242058231
Market cap (USD): 7676494.866028709
Debt to equity: 1.2692567240402375
Current ratio: 1.6292435130958214
Quick ratio: 1.6292435130958214
Interest coverage ratio: -9.678253706754532
COGS to revenue (%): 69.09958815811088
Buyback yield (%): 0
Retained earnings: 5412506.897357961
Receivables turnover: 1.0143533658140966
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.710992815894334
Revenue growth (%): -1.7587298040807455
Rule of 40 score: -1.7587298040807455
Financial ratios for CTE.NS — annual report dated 2025-03-31
Total revenue: 23254746.317512274
Gross profit: 1538052.373158756
Operating income: -4902326.397007247
Net income: -5618669.6282440955
Capital expenditures: 3914916.997895721
Operating cash flow: 6095522.562543838
Depreciation & amortization: 1766997.8957212998
Net tangible assets: 7943242.92728548
Owner earnings: -7766588.730418516
Return on net tangible assets (%): -97.77604438786398
Buffett classification: The Gruesome
Stock price: 0.3987629828451395
Shares outstanding: 19250771
Book value: 7943242.927285479
P/B ratio: 0.966418242058231
Market cap (USD): 7676494.866028709
Debt to equity: 1.2692574304783912
Current ratio: 1.6292450158824503
Quick ratio: 1.6292450158824503
Interest coverage ratio: -4.477980906819298
COGS to revenue (%): 93.38607116087735
SG&A to revenue (%): 2.0390778052202605
Free cash flow (dilution-adjusted): 2173439.326630816
Buyback yield (%): 0
Receivables turnover: 3.993268974045501
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -33.62776860034322
FCF margin (%): 9.346218173939315
Revenue growth (%): -5.967290020058208
Rule of 40 score: 3.378928153881107
Financial ratios for CTE.NS — quarterly report dated 2025-06-30
Total revenue: 5881301.193540839
Gross profit: 916686.1689679383
Operating income: -41376.08237772057
Net income: 69588.11139714486
Capital expenditures: 0
Depreciation & amortization: 397402.29347062955
Owner earnings: 466990.4048677744
Buffett classification: The Gruesome
Stock price: 0.5624853732740464
P/E ratio: 38.90131839456869
Shares outstanding: 19250771
Market cap (USD): 10828277.111748187
Effective tax rate (%): 43.41041012465506
Interest coverage ratio: -0.232662192393736
COGS to revenue (%): 84.41354831521478
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -0.4362824401219488
Rule of 40 score: -0.4362824401219488
Financial ratios for CTE.NS — quarterly report dated 2025-09-30
Total revenue: 4972818.48928974
Gross profit: 561702.3675310033
Operating income: -364937.9932356257
Net income: -587576.099210823
Capital expenditures: 0
Depreciation & amortization: 360462.2322435175
Net tangible assets: 7376922.209695603
Owner earnings: -227113.86696730548
Return on net tangible assets (%): -3.0787076305184056
Buffett classification: The Gruesome
Stock price: 0.41803833145434044
Shares outstanding: 19250771
Book value: 7642401.35287486
P/B ratio: 1.0530145979604089
Market cap (USD): 8047560.188049605
Debt to equity: 1.1765413103479814
Current ratio: 1.8855105011516649
Quick ratio: 1.8855105011516649
Interest coverage ratio: -1.1367866549604917
COGS to revenue (%): 88.70454715488259
Buyback yield (%): 0
Receivables turnover: 0.8284886232583649
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.5224955640080324
Revenue growth (%): -15.4469678452932
Rule of 40 score: -15.4469678452932
Financial ratios for CTE.NS — quarterly report dated 2025-12-31
Total revenue: 5210504.622925254
Gross profit: 1063406.4832349338
Operating income: 409502.06082210096
Net income: 139523.22602205636
Capital expenditures: 0
Depreciation & amortization: 335891.72329285956
Owner earnings: 475414.9493149159
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.43979057591623033
P/E ratio: 15.170068644311376
Shares outstanding: 19250771
Market cap (USD): 8466307.664921464
Effective tax rate (%): 22.648384905194245
Interest coverage ratio: 2.1135514287356982
COGS to revenue (%): 79.59110373770436
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 4.779706601948824
Rule of 40 score: 4.779706601948824
Financial ratios for CVL.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.38345864661654133
Shares outstanding: 509625000
Market cap (USD): 195420112.78195488
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVL.AX — annual report dated 2022-06-30
Total revenue: 558134482.7586207
Gross profit: 62646206.89655173
Operating income: 49008275.862068966
Net income: 35008275.862068966
Capital expenditures: 4531034.482758621
Operating cash flow: 1223448.275862069
Depreciation & amortization: 11448275.862068966
Net tangible assets: 256126206.89655173
Owner earnings: 41925517.24137931
Return on net tangible assets (%): 16.369085283925223
Capex to operating income (%): 9.245447637274493
Buffett classification: The Great
Stock price: 0.3310344827586207
P/E ratio: 4.818959063866672
Shares outstanding: 509625000
Book value: 255940689.65517244
P/B ratio: 0.6591505575106301
Market cap (USD): 168703448.27586207
Debt to equity: 0.3500838017428607
Current ratio: 1.2428073067412932
Quick ratio: 1.240257997738207
Effective tax rate (%): 27.49524884614835
Interest coverage ratio: 21.724854784469578
COGS to revenue (%): 88.77578633254869
SG&A to revenue (%): 0.7711650263500948
Free cash flow (dilution-adjusted): -4527586.206896552
Buyback yield (%): 0
Retained earnings: 146585517.24137932
Inventory turnover: 1350.4849624060148
Receivables turnover: 8.570679685679792
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.745652619647256
FCF margin (%): -0.8111998714930896
Rule of 40 score: -0.8111998714930896
Financial ratios for CVL.AX — annual report dated 2023-06-30
Total revenue: 550242384.1059602
Gross profit: 72298675.49668874
Operating income: 56087417.218543045
Net income: 38194039.73509934
Capital expenditures: 12882119.205298014
Operating cash flow: 63072847.682119206
Depreciation & amortization: 12197350.993377483
Net tangible assets: 278715231.78807944
Owner earnings: 37509271.52317881
Return on net tangible assets (%): 13.457919498170416
Capex to operating income (%): 22.967930855334625
Buffett classification: The Great
Stock price: 0.46357615894039733
P/E ratio: 6.185520087389246
Shares outstanding: 509625000
Book value: 278549006.6225166
P/B ratio: 0.8481451894752607
Market cap (USD): 236250000
Debt to equity: 0.2706432815274994
Current ratio: 1.435715198119715
Quick ratio: 1.432256086656618
Effective tax rate (%): 30.153443702995
Interest coverage ratio: 97.45914844649023
COGS to revenue (%): 86.86057679577695
SG&A to revenue (%): 0.9308360192859017
Free cash flow (dilution-adjusted): 49196688.74172185
Buyback yield (%): 0
Retained earnings: 165562251.65562913
Inventory turnover: 1066.0192023633679
Receivables turnover: 7.71735617023648
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.631862464777415
FCF margin (%): 8.940912252998679
Revenue growth (%): -1.414013807864587
Rule of 40 score: 7.526898445134092
Financial ratios for CVL.AX — annual report dated 2024-06-30
Total revenue: 688982000
Gross profit: 79354000
Operating income: 61197333.333333336
Net income: 42939333.333333336
Capital expenditures: 16732000
Operating cash flow: 47569333.333333336
Depreciation & amortization: 13117333.333333334
Net tangible assets: 325646000
Owner earnings: 39324666.66666667
Return on net tangible assets (%): 12.075894273741017
Capex to operating income (%): 27.341060612662858
Buffett classification: The Good
Stock price: 0.5666666666666667
P/E ratio: 6.725477029607663
Shares outstanding: 509625000
Book value: 325478666.6666667
P/B ratio: 0.8872701334240032
Market cap (USD): 288787500
Debt to equity: 0.2484484390169965
Current ratio: 1.4776601101105233
Quick ratio: 1.4747670262729982
Effective tax rate (%): 29.600725754445794
Interest coverage ratio: 114.60174781523096
COGS to revenue (%): 88.4824276976757
SG&A to revenue (%): 0.7520273872660437
Free cash flow (dilution-adjusted): 30519333.333333336
Buyback yield (%): 0
Retained earnings: 190993333.33333334
Inventory turnover: 1304.4821683309558
Receivables turnover: 10.98411061984525
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.741607598631767
FCF margin (%): 4.429627092338165
Revenue growth (%): 25.214272818962385
Rule of 40 score: 29.64389991130055
Financial ratios for CVL.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 309052795.03105587
Buffett classification: The Gruesome
Stock price: 0.7453416149068323
Shares outstanding: 509625000
Book value: 308896894.40993786
P/B ratio: 1.2296812540717923
Market cap (USD): 379844720.4968944
Debt to equity: 0.2425159453394568
Current ratio: 1.6452200660247054
Quick ratio: 1.6452200660247054
Buyback yield (%): 0
Retained earnings: 183344720.4968944
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CVL.AX — annual report dated 2025-06-30
Total revenue: 529794771.24183005
Gross profit: 60745098.039215684
Operating income: 41212418.30065359
Net income: 27801307.189542484
Capital expenditures: 3095424.836601307
Operating cash flow: 39811764.705882356
Depreciation & amortization: 14008496.732026143
Net tangible assets: 346903921.5686274
Owner earnings: 38714379.084967315
Return on net tangible assets (%): 11.159971588072265
Capex to operating income (%): 7.510903179763699
Buffett classification: The Great
Stock price: 0.6928104575163399
P/E ratio: 12.699889505360165
Shares outstanding: 509625000
Book value: 346739869.28104573
P/B ratio: 1.0182663163132974
Market cap (USD): 353073529.4117647
Debt to equity: 0.22715980034381883
Current ratio: 1.8205521385927625
Quick ratio: 1.8168426512123483
Effective tax rate (%): 29.779612051176223
Interest coverage ratio: 78.32919254658384
COGS to revenue (%): 88.53422092165421
SG&A to revenue (%): 1.3893652246646253
Free cash flow (dilution-adjusted): 36433333.333333336
Buyback yield (%): 0
Retained earnings: 195265359.47712418
Inventory turnover: 1090.6474164133738
Receivables turnover: 15.70264039828752
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.58456452956777
FCF margin (%): 6.876876728687642
Revenue growth (%): -23.10470066825693
Rule of 40 score: -16.227823939569287
Financial ratios for CVL.AX — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 346903921.5686274
Buffett classification: The Gruesome
Stock price: 0.6928104575163399
Shares outstanding: 509625000
Book value: 346739869.28104573
P/B ratio: 1.0182663163132974
Market cap (USD): 353073529.4117647
Debt to equity: 0.22715980034381883
Current ratio: 1.8205521385927625
Quick ratio: 1.8168426512123483
Buyback yield (%): 0
Retained earnings: 195265359.47712418
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYC.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.173913043478261
Shares outstanding: 125734145
Market cap (USD): 147600952.82608697
Buyback yield (%): 0.8138777435693559
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYC.AX — annual report dated 2022-12-31
Total revenue: 15688376.351351352
Gross profit: 10660938.513513513
Operating income: -5158164.864864865
Net income: -4467239.864864865
Capital expenditures: 860829.0540540541
Depreciation & amortization: 629381.0810810811
Net tangible assets: 21013654.72972973
Owner earnings: -4698687.837837839
Return on net tangible assets (%): -22.360164846480615
Buffett classification: The Gruesome
Stock price: 0.7837837837837838
Shares outstanding: 125734145
Book value: 24686898.64864865
P/B ratio: 3.991930510247119
Market cap (USD): 98548383.91891892
Debt to equity: 0.11855462233633607
Current ratio: 4.646144554143033
Quick ratio: 3.60115990001618
Interest coverage ratio: -113.20823323545987
COGS to revenue (%): 32.045622346411825
R&D to revenue (%): 14.815496255038536
SG&A to revenue (%): 59.817237731997906
Free cash flow (dilution-adjusted): -5549245.27027027
Buyback yield (%): 0
Retained earnings: -19643806.756756756
Inventory turnover: 0.8972514032878199
Receivables turnover: 3.0130705519382563
Capitalized R&D asset: 2324310.810810811
ROCI (R&D-adjusted, %): -11.856127077014534
FCF margin (%): -35.37169905917175
Rule of 40 score: -35.37169905917175
Financial ratios for CYC.AX — annual report dated 2023-12-31
Total revenue: 18040677.397260275
Gross profit: 11016186.301369863
Operating income: -6866330.821917809
Net income: -3219730.1369863013
Capital expenditures: 162207.53424657535
Depreciation & amortization: 643036.9863013698
Net tangible assets: 18166717.12328767
Owner earnings: -2738900.684931507
Return on net tangible assets (%): -15.076475657897193
Buffett classification: The Gruesome
Stock price: 1.3150684931506849
Shares outstanding: 125734145
Book value: 22095535.61643836
P/B ratio: 7.4833674762663565
Market cap (USD): 165349012.60273972
Debt to equity: 0.13104044882059793
Current ratio: 3.4832375673948155
Quick ratio: 2.315610703529257
Interest coverage ratio: -418.83613954460003
COGS to revenue (%): 38.93695863636017
R&D to revenue (%): 14.006076602612158
SG&A to revenue (%): 60.92959483608371
Free cash flow (dilution-adjusted): -5278149.315068494
Buyback yield (%): 0
Retained earnings: -23738679.452054795
Inventory turnover: 1.0132128817026174
Receivables turnover: 3.3361890034177097
Capitalized R&D asset: 4084079.3391336547
ROCI (R&D-adjusted, %): -20.127255007843598
Rosenberg metric: 0.1528400531478083
FCF margin (%): -29.25693530704148
Revenue growth (%): 14.993910097690266
Rule of 40 score: -14.263025209351214
Financial ratios for CYC.AX — annual report dated 2024-12-31
Total revenue: 17125826.708074532
Gross profit: 11138378.881987577
Operating income: -9021472.04968944
Net income: -8197278.2608695645
Capital expenditures: 499089.44099378877
Depreciation & amortization: 917022.9813664596
Net tangible assets: 22878129.813664597
Owner earnings: -7779344.720496894
Return on net tangible assets (%): -34.00341192159188
Buffett classification: The Gruesome
Stock price: 0.9875776397515528
Shares outstanding: 125734145
Book value: 26540291.30434782
P/B ratio: 4.678631019205794
Market cap (USD): 124172230.1552795
Debt to equity: 0.19391035343450272
Current ratio: 3.9945807365361663
Quick ratio: 2.7460549841023187
Interest coverage ratio: -401.04288041527457
COGS to revenue (%): 34.96151122015019
R&D to revenue (%): 1.3238368943407948
SG&A to revenue (%): 89.30287302447313
Free cash flow (dilution-adjusted): -8413827.329192545
Buyback yield (%): 0.5726943361678127
Retained earnings: -29724279.50310559
Inventory turnover: 0.7276582009649832
Receivables turnover: 3.6747566384655164
Capitalized R&D asset: 2686690.6142365034
ROCI (R&D-adjusted, %): -30.23670704993545
Rosenberg metric: 0.048358798167545174
FCF margin (%): -49.12946669736866
Revenue growth (%): -5.0710440026197405
Rule of 40 score: -54.200510699988406